Ernexa Therapeutics (ERNAW) Other Working Capital Changes (2010 - 2026)

Ernexa Therapeutics (ERNAW) has 7 years of Other Working Capital Changes data on file, last reported at -$75000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 44.23% year-over-year to -$75000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$231000.0 (up 87.73% YoY) and the FY2025 annual result came in at -$208000.0, up 87.81% from the prior year.
• Other Working Capital Changes eased to -$75000.0 in Q1 2026, from -$63000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $813000.0 in Q3 2023 to a low of -$487000.0 in Q3 2024.
• A 5-year average of $51666.7 and a median of -$47000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2024 — Other Working Capital Changes slumped 362.48% — and 2025, when it surged 97.96%.
• Tracing ERNAW's Other Working Capital Changes over 4 years: stood at $543000.0 in 2023, then slumped by 109.39% to -$51000.0 in 2024, then decreased by 23.53% to -$63000.0 in 2025, then slipped by 19.05% to -$75000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$75000.0 (Q1 2026), -$63000.0 (Q4 2025), and -$54000.0 (Q3 2025), per Business Quant data.